Pharmaceutical Market Europe – October 2026
Harnessing the power of social media for patient engagement; The next phase of oral GLP-1s; Incentivising new treatments for rare diseases
Pharmaceutical Market Europe – September 2026
Celebrating the Communiqué Awards 2026!; Forging a connection with patients through creativity; GLP-1s and the consumer lifestyle shift
Pharmaceutical Market Europe – July/August 2026
Celebrating the Communiqué Awards 2026!; Forging a connection with patients through creativity; GLP-1s and the consumer lifestyle shift
Pharmaceutical Market Europe – June 2026
Steering GenAi into the pharma fast lane; ASCO 2026 – translating emerging science into better patient outcomes; Welcoming new PMEA chair
Pharmaceutical Market Europe – May 2026
The impact of weight loss medication on behaviour change; Why TB is difficult to cure and hard to treat; Finding a cure for lupus
Pharmaceutical Market Europe – April 2026
The impact of weight loss medication on behaviour change; Why TB is difficult to cure and hard to treat; Finding a cure for lupus
Pharmaceutical Market Europe – March 2026
Comms excellence: pushing communications to new heights; the implementation gap in medicines access; Closing the hormonal gap in menopause
Pharmaceutical Market Europe – February 2026
Special feature on GenAI and its impact on pharma – A focus on Rare Disease Day on 28 February – Top Five Most Studied Diseases report
Pharmaceutical Market Europe – January 2026
Alzheimer’s disease – breaking down barriers; ASH 2025 – a call to ‘Fight 4 Haematology’; Oral health – the link to autoimmune diseases
Pharmaceutical Market Europe – December 2025
Thermo Fisher Scientific’s Martin Danielson talks to PME; Celebrating the 2025 PMEAs; Redefining the prostate cancer landscape
Pharmaceutical Market Europe – November 2025
ESMO celebrates 50 years of focusing on oncology research; Improving cardiovascular disease therapy; Global pharma pricing impact on supply chains
Pharmaceutical Market Europe – October 2025
Unravelling the journey on the ‘Patient Metro’; Diagnosing Alzheimer’s takes sensitivity, access and education; Advances in clinical pathway management